tirzepatide for visceral fat Where Do You Lose Weight First on Tirzepatide? GLP-1 Meds, CoolSculpting for Weight

Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis

Clinical research shows that Zepbound can help patients achieve significant weight loss when combined with a healthy diet and increased physical activity

It works on appetite and satiety through different pathways

In SURPASS-2, weight loss with tirzepatide 15 mg was particularly notable, averaging 11.2 kg compared with 5.7 kg for semaglutide 1 mg [12]

On 8 November 2023, Tirzepatide, branded as Zepbound in the US, received FDA approval as the first dual-target agonist for the treatment of obesity, further highlighting its potential in medical treatment options